Stephen Fortmann to Cardiovascular Diseases
This is a "connection" page, showing publications Stephen Fortmann has written about Cardiovascular Diseases.
Connection Strength
3.696
-
Prevalence of cardiovascular disease among Asian, Pacific Islander and multi-race populations in Hawai'i and California. BMC Public Health. 2023 05 15; 23(1):885.
Score: 0.581
-
Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence. JAMA. 2016 Nov 15; 316(19):1971-1972.
Score: 0.370
-
Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer. Ann Intern Med. 2014 May 06; 160(9):656.
Score: 0.311
-
Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: An updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Dec 17; 159(12):824-34.
Score: 0.303
-
The association between different A1C-based measures of glycemia and risk of cardiovascular disease hospitalization. Diabetes Care. 2014; 37(1):167-72.
Score: 0.296
-
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group. Circulation. 2004 Dec 21; 110(25):e554-9.
Score: 0.162
-
Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol. 2004 Feb; 15(2):420-6.
Score: 0.153
-
Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes. N Engl J Med. 2022 09 22; 387(12):1075-1088.
Score: 0.139
-
An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease. Kidney Int. 2001 Sep; 60(3):1106-13.
Score: 0.129
-
Does SLE widen or narrow race/ethnic disparities in the risk of five co-morbid conditions? Evidence from a community-based outpatient care system. Lupus. 2019 Dec; 28(14):1619-1627.
Score: 0.114
-
Use of Statins in Adults Older Than 75 Years-Reply. JAMA. 2017 03 14; 317(10):1081.
Score: 0.095
-
The long-term effects of a cardiovascular disease prevention trial: the Stanford Five-City Project. Am J Public Health. 1996 Dec; 86(12):1773-9.
Score: 0.093
-
Community intervention trials: reflections on the Stanford Five-City Project Experience. Am J Epidemiol. 1995 Sep 15; 142(6):576-86.
Score: 0.085
-
American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation. 2013 Apr 23; 127(16):1730-53.
Score: 0.072
-
Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992 Jun; 82(6):816-20.
Score: 0.068
-
The Behavioral Risk Factor Survey and the Stanford Five-City Project Survey: a comparison of cardiovascular risk behavior estimates. Am J Public Health. 1992 Mar; 82(3):412-6.
Score: 0.067
-
Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: a cohort study. BMC Nephrol. 2011 Sep 14; 12:44.
Score: 0.065
-
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011 Sep 11; 478(7367):103-9.
Score: 0.065
-
Use of educational resources for cardiovascular risk reduction in the Stanford Five-City Project. Am J Prev Med. 1991 Mar-Apr; 7(2):82-8.
Score: 0.062
-
Validation of a new brief physical activity survey among men and women aged 60-69 years. Am J Epidemiol. 2006 Sep 15; 164(6):598-606.
Score: 0.045
-
American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation. 2003 Feb 04; 107(4):645-51.
Score: 0.036
-
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003 Jan 28; 107(3):499-511.
Score: 0.036
-
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002 Jul 16; 106(3):388-91.
Score: 0.034
-
Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation. 2000 Dec 19; 102(25):3137-47.
Score: 0.031
-
Primordial prevention of cardiovascular disease risk factors: panel summary. Prev Med. 1999 Dec; 29(6 Pt 2):S130-5.
Score: 0.029
-
The interplay of socioeconomic status and ethnicity on Hispanic and white men's cardiovascular disease risk and health communication patterns. Health Educ Res. 1998 Sep; 13(3):407-17.
Score: 0.026
-
Lipoprotein(a), a clinically elusive lipoprotein particle. Circulation. 1997 Jan 21; 95(2):295-6.
Score: 0.023
-
Weight variability effects: a prospective analysis from the Stanford Five-City Project. Am J Epidemiol. 1995 Mar 01; 141(5):461-5.
Score: 0.021
-
Cardiovascular disease risk factors: improvements in knowledge and behavior in the 1980s. Am J Public Health. 1993 Apr; 83(4):590-3.
Score: 0.018
-
Changes in adult cigarette smoking prevalence after 5 years of community health education: the Stanford Five-City Project. Am J Epidemiol. 1993 Jan 01; 137(1):82-96.
Score: 0.018
-
Trends in cardiovascular disease risk factors by educational level: the Stanford Five-City Project. Prev Med. 1992 Sep; 21(5):592-601.
Score: 0.017
-
Effect of long-term community health education on body mass index. The Stanford Five-City Project. Am J Epidemiol. 1991 Aug 01; 134(3):235-49.
Score: 0.016
-
Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA. 1990 Jul 18; 264(3):359-65.
Score: 0.015
-
Social class disparities in risk factors for disease: eight-year prevalence patterns by level of education. Prev Med. 1990 Jan; 19(1):1-12.
Score: 0.014
-
Distribution of asymmetric dimethylarginine among 980 healthy, older adults of different ethnicities. Clin Chem. 2010 Jan; 56(1):111-20.
Score: 0.014
-
Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the expert panel on population and prevention science). Circulation. 2008 Jul 22; 118(4):428-64.
Score: 0.013
-
Moderate-intensity physical activity and cardiovascular risk factors: the Stanford Five-City Project. Prev Med. 1986 Nov; 15(6):561-8.
Score: 0.012
-
Vigorous physical activity and cardiovascular risk factors in young adults. J Chronic Dis. 1986; 39(2):115-20.
Score: 0.011
-
Health behavior change at the worksite: cardiovascular risk reduction. Prog Behav Modif. 1986; 20:161-97.
Score: 0.011
-
The Stanford Five-City Project: design and methods. Am J Epidemiol. 1985 Aug; 122(2):323-34.
Score: 0.011
-
Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA Project. Am J Public Health. 2001 Feb; 91(2):206-12.
Score: 0.008
-
Health-related risk factors in a sample of Hispanics and whites matched on sociodemographic characteristics. The Stanford Five-City Project. Am J Epidemiol. 1993 Jun 15; 137(12):1365-75.
Score: 0.005
-
Improved cholesterol-related knowledge and behavior and plasma cholesterol levels in adults during the 1980s. JAMA. 1992 Sep 23-30; 268(12):1566-72.
Score: 0.004
-
A comparison of statistical methods for evaluating risk factor changes in community-based studies: an example from the Stanford Three-Community Study. J Chronic Dis. 1981; 34(11):565-71.
Score: 0.002